Benzamide derivatives and their use as HSP90 inhibtors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9321718
APP PUB NO 20130143926A1
SERIAL NO

13703387

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a compound which is (a) a phenylamide derivative of formula (I) or a tautomer thereof, or (b) a pharmaceutically acceptable salt, N-oxide, hydrate, prodrug or solvate thereof: wherein R1, R2, R3, R4, R5, R6 and R7 are as defined herein. The compounds are useful in the treatment of diseases mediated by HSP90.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHROMA THERAPEUTICS LTDABINGDON OXFORDSHIRE OX14 4RY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Donald, Alastair David Graham Oxfordshire, GB 12 61
McDermott, Joanne Oxfordshire, GB 4 44
Moffat, David Festus Charles Oxfordshire, GB 50 1520
Patel, Sanjay Ratilal Oxfordshire, GB 12 246

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 26, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00